.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Dow
Federal Trade Commission
Cipla
McKinsey
Chubb
Baxter
Fish and Richardson
Medtronic
Chinese Patent Office

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,266,331

« Back to Dashboard

Summary for Patent: 5,266,331

Title: Controlled release oxycodone compositions
Abstract:A solid controlled release, oral dosage form, the dosage form comprising a therapeutically effective amount of oxycodone or a salt thereof in a matrix wherein the dissolution rate in vitro of the dosage form, when measured by the USP Paddle Method of 100 rpm in 900 ml aqueous buffer (pH between 1.6 and 7.2) at 37.degree. C. is between 12.5% and 42.5% (by weight) oxycodone released after 1 hour, between 25% and 55% (by weight) oxycodone released after 2 hours, between 45% and 75% (by weight) oxycodone released after 4 hours and between 55% and 85% (by weight) oxycodone released after 6 hours, the in vitro release rate being independent of pH between pH 1.6 and 7.2 and chosen such that the peak plasma level of oxycodone obtained in vivo occurs between 2 and 4 hours after administration of the dosage form.
Inventor(s): Oshlack; Benjamin (New York, NY), Minogue; John J. (Mount Vernon, NY), Chasin; Mark (Manalpan, NJ)
Assignee: Euroceltique, S.A. (LU)
Application Number:07/800,549
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form; Composition; Process;

No matches for this query

International Patent Family for Patent: 5,266,331

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria144418► Subscribe
Austria226822► Subscribe
Austria261725► Subscribe
Austria261726► Subscribe
Austria261727► Subscribe
Austria332691► Subscribe
Austria360421► Subscribe
Austria365041► Subscribe
Austria454150► Subscribe
Australia3147693► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
McKesson
Novartis
Queensland Health
AstraZeneca
Accenture
Express Scripts
Farmers Insurance
Johnson and Johnson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot